Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

People with alopecia who are more resilient tend to feel less stressed.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

People with certain skin diseases often have more trouble understanding and describing their emotions, which can affect their health and treatment results.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Use benzoyl peroxide, retinoids, antibiotics, and isotretinoin for acne, and combine treatments for better results.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Minoxidil is the only approved cream for hair loss, but new treatments are being looked into.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

A new medical syndrome may include skin changes, hair loss, sweating issues, bone malformations, leg swelling, and low cortisol.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.